Vered Caplan - 23 Jul 2024 Form 4 Insider Report for Orgenesis Inc. (ORGS)

Reporting relationship: CEO & CHAIRMAN OF THE BOARD, Director
Issuer ticker: ORGS
Reported as of: 23 Jul 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 25 Jul 2024, 11:31:01 UTC
Prior SEC filing: 16 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Vered Caplan

Key filing fact

Vered Caplan filed Form 4 for Orgenesis Inc. (ORGS) on 25 Jul 2024.

Key facts

This page summarizes Vered Caplan's Form 4 filing for Orgenesis Inc. (ORGS).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 25 Jul 2024, 11:31.

Change

Previous filing in this sequence was filed on 16 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ORGS transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +85,000
Change %
Price: $0.000000
Shares after: 85,000
Date: 23 Jul 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 85,000
Exercise price: $0.6400
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Equal vesting over the next eight quarters with the vesting of the first 10,625 options commencing on September 30, 2024, subject to the reporting person's continued service through the applicable vesting dates.